Nuvalent Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Nuvalent Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvalent Inc - Ordinary Shares - Class A
Rating: 1.77458325
Author: Trendlyne DVM scores

about

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

90.88 -6.30 (-6.48%)

63.63% Gain from 52W Low

604.2K

XNAS Volume

XNAS 22 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

3.8 / 100

Technically Moderately Bullish

67.2 / 100

No estimates available

Nuvalent Inc Ordinary Shares Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvalent Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

63.63% Gain from 52W Low

SWOT Analysis

Nuvalent Inc Ordinary Shares Live Price Chart